First-in-Human Experience of Using a Universal Steerable Sheath in Implanting Left Atrial Appendage Closure Devices
- PMID: 36444320
- PMCID: PMC9700041
- DOI: 10.1016/j.jacasi.2022.08.003
First-in-Human Experience of Using a Universal Steerable Sheath in Implanting Left Atrial Appendage Closure Devices
Abstract
Left atrial appendage (LAA) closure (LAAC) device implantation may be challenging in cases with difficult LAA anatomy. A deflectable sheath to approach multiple LAA positions may be helpful. We used a deflectable sheath to implant LAAC devices in 20 patients and included 60 cases using the standard sheaths for comparison. The procedures were successful in all patients without peri-procedural complications. After a median follow-up of 1.52 (IQR: 0.76-2.33) years, none of the patients in the deflectable sheath group had peri-device leak ≥3 mm and experienced thromboembolic stroke. In the standard sheath group, after follow-up of 2.03 (IQR: 0.87-3.19) years, 2 had peri-device leak ≥3 mm and 1 experienced thromboembolic stroke. We first proved the idea of using a universal steerable sheath for LAAC device implantation in difficult LAA anatomy, which also allows rapid switching of different LAAC devices.
Keywords: AF, atrial fibrillation; LAA, left atrial appendage; LAAC, left atrial appendage closure; deflectable sheath; left atrial appendage closure device; steerable sheath.
© 2022 The Authors.
Conflict of interest statement
The work was supported by grants from the Ministry of Science and Technology in Taiwan (MOST 109-2314-B-002-244-MY3 and MOST 110-2314-B-002-198 -MY3). The Ministry of Science and Technology had no role in the conduct of this study. All authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Figures



References
-
- Holmes D.R., Reddy V.Y., Turi Z.G., et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374:534–542. - PubMed
-
- Chang S.N., Lai L.P., Chiang F.T., Lin J.L., Hwang J.J., Tsai C.T. C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study. J Thromb Haemost. 2017;15:1541–1546. - PubMed
-
- Kleinecke C., Gomez Monterrosas O., Scalone G., et al. First-in-human experience of left atrial appendage occlusion with the steerable FuStar sheath. J Interv Cardiol. 2018;31:532–537. - PubMed
LinkOut - more resources
Full Text Sources